Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease

Author： Nilsson Jan   Fredrikson Gunilla Nordin   Chyu Kuang-Yuh   Shah Prediman K   Björkbacka Harry  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.3, 2006-06, pp. : 321-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a): An Emerging Cardiovascular Risk Factor

By Lippi Giuseppe   Guidi Giancesare  

Critical Reviews in Clinical Laboratory Sciences, Vol. 40, Iss. 1, 2003-01 ,pp. : 1-42

Informa Healthcare

Access to resources Recommend Favorite

Oxidized Low-Density Lipoprotein Cholesterol and Coronary Artery Disease

By  

Cardiology, Vol. 119, Iss. 2, 2011-09 ,pp. : 106-107

Karger

Access to resources Recommend Favorite

Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research

By Ordovas Jose M  

Future Lipidology, Vol. 2, Iss. 2, 2007-04 ,pp. : 115-118

Future Medicine

Access to resources Recommend Favorite

Drug Therapy for Cardiovascular Disease in the Aged

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 3, 1975-03 ,pp. : 113-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum lipoprotein(a) and cardiovascular disease in non-insulin-dependent diabetes mellitus

By Furuseth Kristian   Berg Kaare   Hanssen Kristian F   Rutle Olav   Bruusgaard Dag   Vaaler Stein  

Scandinavian Journal of Primary Health Care, Vol. 16, Iss. 1, 1998-05 ,pp. : 40-43

Informa Healthcare

Access to resources Recommend Favorite